Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis - Hazebroek, M.R.; Kemna, M.J.; Schalla, S.; Sanders-van Wijk, S.; Gerretsen, S.C.; Dennert, R.; Merken, J.; Kuznetsova, T.; Staessen, J.A.; Brunner-La Rocca, H.P.; van Paassen, P.; Cohen Tervaert, J.W.; et al. (International journal of cardiology, 2015)
Keywords: Aged; Aged, 80 and over; Algorithms; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - epidemiology; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology; Biopsy; Cardiac Imaging Techniques - methods; Cardiovascular; Cardiovascular disease; Cardiovascular Diseases - complications; Cardiovascular Diseases - mortality; Churg-Strauss Syndrome - complications; Churg-Strauss Syndrome - drug therapy; Churg-Strauss Syndrome - epidemiology; Cohort Studies; Coronary Angiography; Echocardiography; Electrocardiography; Female; Granulomatosis with polyangiitis; Granulomatosis with Polyangiitis - complications; Granulomatosis with Polyangiitis - drug therapy; Granulomatosis with Polyangiitis - epidemiology; Granulomatosis with Polyangiitis - immunology; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium - pathology; Patient Outcome Assessment; Predictive Value of Tests; Prevalence; Prognosis; Prospective Studies; Risk Factors; Systemic vasculitis; Granulomatosis with polyangiitis; Cardiovascular disease; Prognosis; Systemic vasculitis